GE Aerospace vs Hims and Hers Health Inc — how do they compare? GE Aerospace trades at $306.99 (market cap $317.10B), while Hims and Hers Health Inc trades at $28.45 (market cap $6.55B). The key difference: GE Aerospace is far larger — about 48.4× Hims and Hers Health Inc's market cap, and GE Aerospace pays a 0.62% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold GE Aerospace for 111 Days and Hims and Hers Health Inc for 21 Days on average.
| GE | HIMS | |
|---|---|---|
Market Cap | $317.10B | $6.55B |
Volume | 6,320,106 | 14,842,814 |
Sector | Industrials | Health |
52-Week High | $381.22 | $62.76 |
52-Week Low | $273.25 | $14.52 |
Typical Hold Time | 111 Days | 21 Days |
Enterprise Value | $326.91B | $7.25B |
Dividend Yield | 0.62% | — |
Signals from Pluang's Aura AI — not financial advice
GE Aerospace trades at $305.62, down 1.22% amid broader market weakness, with technical indicators showing bearish momentum below key moving averages. Fundamentally, the company demonstrates strong profitability with 17.72% net margins and consistent earnings beats, though valuation multiples appear elevated. Recent news highlights the strategic $12 billion CPP acquisition to address supply chain constraints while maintaining robust shareholder returns through dividends and buybacks.
The outlook remains constructive given strong defense demand and operational execution, but high valuation and acquisition integration risks warrant caution. Analyst consensus is strongly bullish with a $409.60 price target representing 34% upside, though near-term technical pressure may persist until the Q3 earnings report provides clearer direction.
Hims & Hers Health trades at $29.54, up slightly by 0.24% on the day. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company reported revenue of $2.35 billion in 2025 but swung to a net loss of $142 million in 2026, with a negative net margin of 5.51%. Analyst consensus is a 'Hold' with a price target of $32.17, but the stock faces significant headwinds from multiple securities class action lawsuits announced in early October 2026.
The outlook for HIMS is clouded by legal risks and profitability challenges despite revenue growth. Investment opportunity hinges on the company's ability to return to profitability and resolve regulatory scrutiny. Key risks include ongoing litigation, FTC complaints, and execution missteps in a competitive telehealth market. Wall Street remains cautious with 65% of analysts recommending Hold.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →